BeStock  
Stocks › Biotechnology › NUVB

Nuvation Bio NUVB

US equityMarket cap rank #2886Biotechnology
$4.95 −$0.19 (-3.70%)
Market closed · Oct 6, 1:30 am ET · Last extended-hours $4.96 +0.20%
Open$5.12
Prev close$5.14
Day range$4.85 – $5.16
Volume9.97M
Market cap$1.74B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.9%last 7 reports
Closed higher2 of 729% of the time
Best reaction+9.5%
Worst reaction-25.3%

Stock move on the day after each report

-6.2%2022/Q1+2.9%2025/Q1-0.4%2025/Q2-6.6%2025/Q3-25.3%2025/Q4+9.5%2026/Q1-4.1%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q26 Aug 2026Pre Market±23.6%-4.08%Within range
2026/Q14 May 2026After Market±18.1%+9.52%Within range
2025/Q42 Mar 2026After Market±30.4%-25.34%Within range
2025/Q33 Nov 2025After Market±24.2%-6.58%Within range
2025/Q27 Aug 2025Pre Market±18.7%-0.43%Within range
2025/Q17 May 2025After Market±24.5%+2.94%Within range
2022/Q19 May 2022None–-6.21%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$62.90M+699.0% YoY
Operating profit-$213.06M-27.2% YoY
Net profit-$204.63M+64.0% YoY
Diluted EPS-$0.60+71.6% YoY

Profitability & balance sheet

Gross margin85.2%
Operating margin-338.7%
Net margin-325.3%
Liabilities / assets65.9%
Cash & investments$660.96M
Total debt$250.43M
Net cash (debt)$410.53M

Discussion

No comments yet — be the first to weigh in on NUVB.

Leave a comment

Scroll to Top